We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

3 hedge funds and large institutions have $7.61M invested in Seelos Therapeutics, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 2 → 3 (+1)

8% more capital invested

Capital invested by funds: $7.07M → $7.61M (+$537K)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
–
Reduced
–
Closed
–
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
-$47K

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$1.6M

Top Sellers

Rank Fund Capital Flow
1
CC
Callan Capital
California
-$26K
2
HighTower Advisors
HighTower Advisors
Illinois
-$24K
3
Wolverine Trading
Wolverine Trading
Illinois
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sarissa Capital Management
Connecticut
$4.9M – – –
AFM
2
Anson Funds Management
Texas
$1.72M +$1.6M +4 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$473K – – –
HVC
4
Healthcare Value Capital
New Jersey
$149K – – –
California Public Employees Retirement System
5
California Public Employees Retirement System
California
$87K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$86K – – –
Franklin Resources
7
Franklin Resources
California
$55K – – –
Northern Trust
8
Northern Trust
Illinois
$23K – – –
Bank of New York Mellon
9
Bank of New York Mellon
New York
$21K – – –
BIT
10
BlackRock Institutional Trust
California
$20K – – –
VKH
11
Virtu KCG Holdings
New York
$13K – – –
GC
12
Guggenheim Capital
Illinois
$10K – – –
MBA
13
McQueen Ball & Associates
Pennsylvania
$8K – – –
MFS
14
MSI Financial Services
Massachusetts
$8K – – –
Group One Trading
15
Group One Trading
Illinois
$5K – – –
BA
16
BlackRock Advisors
Delaware
$4K – – –
BFA
17
BlackRock Fund Advisors
California
$4K – – –
State Street
18
State Street
Massachusetts
$4K – – –
Creative Planning
19
Creative Planning
Kansas
$3K – – –
FANJ
20
Financial Architects (New Jersey)
New Jersey
$3K – – –
Morgan Stanley
21
Morgan Stanley
New York
$3K – – –
Wells Fargo
22
Wells Fargo
California
$3K – – –
AG
23
Advisor Group
Arizona
$2K – – –
Bank of America
24
Bank of America
North Carolina
$2K – – –
BlackRock
25
BlackRock
New York
$1K – – –
1
2

SEEL Hedge Fund Activity: Q3 2016 in Review

3 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q3 2016, worth a combined $7.61M — up 7.6% from $7.07M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new SEEL positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $1.6M. The largest seller was Callan Capital, cutting an estimated $26K.

  • 3 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q3 2016, up from 2 in Q2 2016.
  • Funds reported $7.61M of Seelos Therapeutics, Inc. Common Stock stock for Q3 2016, up 7.6% quarter-over-quarter.
  • 1 fund opened new Seelos Therapeutics, Inc. Common Stock positions in Q3 2016 and 0 closed out, a net change of +1 holder.
  • The largest Seelos Therapeutics, Inc. Common Stock buyer in Q3 2016 was Anson Funds Management, an estimated $1.6M added.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q3 2016 was Callan Capital, an estimated $26K sold.

Based on aggregated 13F filings for Q3 2016.